Feedback (LON:FDBK) Trading 20.8% Higher – Here’s Why

Feedback plc (LON:FDBK) shares were up 20.8% during mid-day trading on Tuesday . The company traded as high as GBX 14.50 and last traded at GBX 14.49. Approximately 347,737 shares were traded during mid-day trading, an increase of 209% from the average daily volume of 112,402 shares. The stock had previously closed at GBX 12.

Feedback Stock Up 1.8%

The company has a market cap of £6.13 million, a PE ratio of -0.55 and a beta of 0.77. The stock has a 50-day simple moving average of GBX 11.13 and a 200 day simple moving average of GBX 10.64.

Feedback (LON:FDBK) last announced its quarterly earnings data on Tuesday, February 17th. The company reported GBX (3.98) earnings per share (EPS) for the quarter. Feedback had a negative net margin of 279.16% and a negative return on equity of 39.71%. As a group, research analysts anticipate that Feedback plc will post -8 earnings per share for the current fiscal year.

Insider Activity at Feedback

In related news, insider Emma Oswick (Stuart) bought 60,459 shares of the stock in a transaction dated Tuesday, December 23rd. The stock was acquired at an average price of GBX 8 per share, for a total transaction of £4,836.72. Also, insider Tom Oakley purchased 60,904 shares of the business’s stock in a transaction on Tuesday, December 23rd. The shares were purchased at an average cost of GBX 8 per share, for a total transaction of £4,872.32. 7.98% of the stock is owned by insiders.

About Feedback

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.